Fundraising Fox
ProtoKinetix
OTC: PKTXDalton, US · Nevada corporation
Find your way into ProtoKinetix
Sign up to see every warm intro you have to ProtoKinetix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ProtoKinetix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ProtoKinetix develops a proprietary anti-aging glycopeptide (AAGP®) designed to improve cell survival and viability, with applications across ophthalmology, dermatology, transplantation, and biomanufacturing. The company conducts research and clinical studies focused on cryopreservation and cell replacement therapies for chronic conditions.
Founders & leadership
Board
EM
Edward McDonoughBoard director
DG
Dr. Geraldine Castelot-Deliencourt
Reported raises · per SEC filings
Form D private placements$6.2M disclosed across 34 rounds · 2015–2025
▶$147.5KraisedDec 2025 · 3 investors · OtherRule 506(b)
▶$147.5KraisedDec 2025 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Edward McDonoughDirector
- Michael GuzzettaExecutive Officer, Director
- Offering amount
- $250K
- Amount sold
- $147.5K
- First sale
- Sep 2025
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b, 4a5
▶$172KraisedAug 2025 · 7 investors · OtherRule 506(b)
▶$172KraisedAug 2025 · 7 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Clarence SmithExecutive Officer, Director
- Edward McDonoughDirector
- Michael GuzzettaExecutive Officer
- Offering amount
- $172K
- Amount sold
- $172K
- First sale
- Jan 2025
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b, 4a5
▶$240KraisedJan 2025 · 8 investors · OtherRule 506(b)
▶$240KraisedJan 2025 · 8 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Edward McDonoughDirector
- Michael GuzzettaExecutive Officer
- Clarence SmithExecutive Officer, Director
- Offering amount
- $240K
- Amount sold
- $240K
- First sale
- Mar 2024
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b, 4a5
▶$135KraisedApr 2024 · 3 investors · OtherRule 506(b)
▶$135KraisedApr 2024 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Clarence SmithExecutive Officer, Director
- Edward McDonoughDirector
- Michael GuzzettaExecutive Officer
- Offering amount
- $200K
- Amount sold
- $135K
- First sale
- Dec 2023
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b, 4a5
▶$429KraisedSep 2023 · 8 investors · OtherRule 506(b)
▶$429KraisedSep 2023 · 8 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Edward McDonoughDirector
- Clarence SmithExecutive Officer, Director
- Michael GuzzettaExecutive Officer
- Offering amount
- $500K
- Amount sold
- $429K
- First sale
- Dec 2022
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b, 4a5
▶$73KraisedDec 2022 · 2 investors · OtherRule 506(b)
▶$73KraisedDec 2022 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Clarence SmithExecutive Officer, Director
- Michael GuzzettaExecutive Officer
- Edward McDonoughDirector
- Offering amount
- $250K
- Amount sold
- $73K
- First sale
- Dec 2022
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b, 4a5
▶$225KraisedOct 2022 · 3 investors · OtherRule 506(b)
▶$225KraisedOct 2022 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michael GuzzettaExecutive Officer
- Clarence SmithExecutive Officer, Director
- Edward P. McDonoughDirector
- Offering amount
- $350K
- Amount sold
- $225K
- First sale
- Jul 2022
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b, 4a5
▶$365KraisedMay 2022 · 7 investors · OtherRule 506(b)
▶$365KraisedMay 2022 · 7 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Clarence SmithExecutive Officer, Director
- Michael GuzzettaExecutive Officer
- Edward P. McDonoughDirector
- Offering amount
- $1M
- Amount sold
- $365K
- First sale
- Mar 2022
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b, 4a5
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
AllureAllure is a beauty journalism publication that provides product reviews, trend reporting, and expert guidance on makeup, hair, skincare, and wellness. The publication serves beauty consumers and industry professionals through its website, social channels, and subscription service.
Refinery 29Refinery29 is a digital media publication producing lifestyle content for a primarily female audience, covering topics such as fashion, shopping, wellness, and horoscopes.
EpiphanydermatologyEpiphany Dermatology operates dermatology clinics staffed by board-certified dermatologists, physician assistants, nurse practitioners, and aestheticians, offering medical services such as skin cancer care, Mohs surgery, biopsies, and acne treatment, as well as cosmetic services like chemical peels, injectable fillers, and body contouring. It also sells physician-approved skin care products and aims to provide accessible dermatologic care across multiple U.S. locations.
TatchaTatcha sells skincare products including cleansers, moisturizers, and treatment serums focused on hydration, firming, and brightening. The brand sells directly to consumers online with subscription and set-curation options.
Companies working in the same space as ProtoKinetix.
In the news
Frequently asked questions
- What does ProtoKinetix do?
- ProtoKinetix develops a proprietary anti-aging glycopeptide (AAGP®) designed to improve cell survival and viability, with applications across ophthalmology, dermatology, transplantation, and biomanufacturing. The company conducts research and clinical studies focused on cryopreservation and cell replacement therapies for chronic conditions.
- How much funding has ProtoKinetix raised?
- ProtoKinetix has disclosed $6.2M raised across 34 rounds.
- Where is ProtoKinetix headquartered?
- ProtoKinetix is headquartered in Dalton, US.